Oravax(orvx) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oravax(orvx)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LTK007 who wrote (115)	5/6/1999 7:21:00 AM
From: Ploni	Read Replies (1) of 127

Peptide's Finance Director was kind enough to respond to my e-mailed question and explain that they aren't planning to trade ADR's at this time, under advice of their investment bankers. The concern was that the company wouldn't be big enough or the stock liquid enough to support ADR's, though they'll review the matter in the future. Meanwhile, ORVX stock has been moving closer to the 85 cents at which it will convert. I still haven't checked with my broker regarding the ease of trading London stocks. I tried buying more ORVX at 0.51 last week when it was trading between 0.51-0.53, but the market makers didn't want to part with any at that price. As of today we'll get right around 1/2 share PTE for each share of ORVX. That will obviously change depending on where PTE and the English Pound trade.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next